[1] Dewan MC, Baticulon RE, Rattani A, Johnston JM, Warf BC, Harkness W. Pediatric neurosurgical workforce, access to care, equipment and training needs worldwide[J]. Neurosurg Focus, 2018, 45:E13. [2] Gong J. Ma Zhenyu's discussion on the history and prospect of pediatric neurosurgery[M]//Gong J. Pediatric neurosurgery surgical notes (2). Beijing:China Science and Technology Press, 2023:159-163.[宫剑. 马振宇谈小儿神经外科的历史与展望[M]//宫剑. 小儿神经外科手术笔记(2). 北京:中国科学技术出版社, 2023:159-163.] [3] Mei F, Qiu RW, Mai YY, Chen SX, Liu SJ, Min XD, Yin ZH, Bao Y, Qi ST. History, status and prospect of pediatric brain tumors[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2020, 20:258-262.[梅芬, 邱若薇, 麦益颖, 陈舒娴, 刘思洁, 闵旭东,尹铸豪, 包赟, 漆松涛. 儿童脑肿瘤治疗历史、现状及展望[J]. 中国现代神经疾病杂志, 2020, 20:258-262.] [4] Pak-Yin Liu A, Moreira DC, Sun C, Krull L, Gao Y, Yang B, Zhang C, He K, Yuan X, Chi-Fung Chan G, Sun X, Ma X, Qaddoumi IA. Challenges and opportunities for managing pediatric central nervous system tumors in China[J]. Pediatr Investig, 2020, 4:211-217. [5] Liu APY, Liu Q, Shing MMK, Ku DTL, Fu E, Luk CW, Ling SC, Cheng KKF, Kwong DLW, Ho WWS, Ng HK, Gajjar A, Yasui Y, Chan GCF, Armstrong GT. Incidence and outcomes of CNS tumors in Chinese children:comparative analysis with the surveillance, epidemiology, and end results program[J]. JCO Glob Oncol, 2020, 6:704-721. [6] Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, Von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System:a summary[J]. Neuro Oncol, 2021, 23:1231-1251. [7] Friedman GK, Johnston JM, Bag AK, Bernstock JD, Li R, Aban I, Kachurak K, Nan L, Kang KD, Totsch S, Schlappi C, Martin AM, Pastakia D, Mcnall-Knapp R, Farouk Sait S, Khakoo Y, Karajannis MA, Woodling K, Palmer JD, Osorio DS, Leonard J, Abdelbaki MS, Madan-Swain A, Atkinson TP, Whitley RJ, Fiveash JB, Markert JM, Gillespie GY. Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas[J]. N Engl J Med, 2021, 384:1613-1622. [8] Kumar R, Liu APY, Northcott PA. Medulloblastoma genomics in the modern molecular era[J]. Brain Pathol, 2020, 30:679-690. [9] Hovestadt V, Ayrault O, Swartling FJ, Robinson GW, Pfister SM, Northcott PA. Medulloblastomics revisited:biological and clinical insights from thousands of patients[J]. Nat Rev Cancer, 2020, 20:42-56. [10] Castellano A, Bailo M, Cicone F, Carideo L, Quartuccio N, Mortini P, Falini A, Cascini GL, Minniti G. Advanced imaging techniques for radiotherapy planning of gliomas[J]. Cancers (Basel), 2021, 13:1063. [11] Donovan LK, Delaidelli A, Joseph SK, Bielamowicz K, Fousek K, Holgado BL, Manno A, Srikanthan D, Gad AZ, Van Ommeren R. Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma[J]. Nat Med, 2020, 26:720-731. [12] Frampton JE. Teserpaturev/G47Δ:first approval[J]. BioDrugs, 2022, 36:667-672. [13] Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, Macdonald SM, Pulsifer MB, Lavally B. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma:a phase 2 single -arm study[J]. Lancet Oncol, 2016, 17:287-298. [14] Cohen AR. Brain tumors in children[J]. N Engl J Med, 2022, 386:1922-1931. [15] Parikh KA, Merchant TE, Boop FA. Suboccipital microsurgical resection of pediatric ependymoma in the foramen of luschka:2- dimensional operative video[J]. Oper Neurosurg (Hagerstown), 2022, 22:e51. [16] Zhang Q, Cheng S, Wang Y, Wang M, Lu Y, Wen Z, Ge Y, Ma Q, Chen Y, Zhang Y, Cao R, Li M, Liu W, Wang B, Wu Q, Jia W, Wang X. Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages[J]. Nat Commun, 2021, 12:6867. [17] Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, Von Deimling A, Ellison DW. The 2021 WHO Classification of Tumors of the Central Nervous System:a summary[J]. Neuro Oncol, 2021, 23:1231-1251. [18] Fujio S, Hanada T, Yonenaga M, Nagano Y, Habu M, Arita K, Yoshimoto K. Surgical aspects in craniopharyngioma treatment[J]. Innovative Surgical Sciences, 2021, 6:25-33. [19] Yu X, Christ SM, Liu R, Wang Y, Hu C, Feng B, Mahadevan A, Kasper EM. Evaluation of long-term outcomes and toxicity after stereotactic phosphorus-32-based intracavitary brachytherapy in patients with cystic craniopharyngioma[J]. Int J Radiat Oncol Biol Phys, 2021, 111:773-784. [20] de Lima FBF, Ferreira Júnior TA, Almeida LCA, Moreira L de S, Figueiredo HPG, Dellaretti M, Costa BS. Intracranial arachnoid cysts in childhood:pathogenesis, clinical features, and management[J]. Arch Pediat Neurosurg, 2022, 4:e1562022. [21] Zhao H, Cao L, Zhao Y, Wang B, Tian S, Ma J. Clinical value of classification in the treatment of children with suprasellar arachnoid cysts[J]. Childs Nerv Syst, 2023, 39:767-773. [22] Beltagy MAE, Enayet AER. Surgical indications in pediatric arachnoid cysts[J]. Childs Nerv Syst, 2023, 39:87-92. [23] Zhao H, Xie W, Cao L, Ni Z, Wang B, Ma J. Predictors for the clinical prognosis of sylvian arachnoid cysts in children[J]. Front Pediatr, 2023, 11:1075087. [24] Kague E, Medina-Gomez C, Boyadjiev SA, Rivadeneira F. The genetic overlap between osteoporosis and craniosynostosis[J]. Front Endocrinol (Lausanne), 2022, 13:1020821. [25] Lapehn S, Gustafson JA, Timms AE, Cunningham ML, Paquette AG. Transcriptomic signatures of single-suture craniosynostosis phenotypes[J]. Int J Mol Sci, 2023, 24:5353. [26] Stanton E, Urata M, Chen JF, Chai Y. The clinical manifestations, molecular mechanisms and treatment of craniosynostosis[J]. Dis Model Mech, 2022, 15:dmm049390. [27] Yu M, Ma L, Yuan Y, Ye X, Montagne A, He J, Ho TV, Wu Y, Zhao Z, Sta Maria N, Jacobs R, Urata M, Wang H, Zlokovic BV, Chen JF, Chai Y. Cranial suture regeneration mitigates skull and neurocognitive defects in craniosynostosis[J]. Cell, 2021, 184:243-256. [28] Arkader A, Boriani S. Management of spine tumors in the young children[M]//Akbarnia BA, Thompson GH, Yazici M, El-Hawary R. The growing spine:management of spinal disorders in young children. Cham:Springer International Publishing, 2022:411-430. [29] Forci K, Bouaiti EA, Alami MH, Mdaghri Alaoui A, Thimou Izgua A. Incidence of neural tube defects and their risk factors within a cohort of Moroccan newborn infants[J]. BMC Pediatrics, 2021, 21:124. [30] Mikulski MF, Well A, Beckerman Z, Fraser CD Jr, Bebbington MW, Moise KJ Jr. Open and endoscopic fetal myelomeningocele surgeries display similar in-hospital safety profiles in a large, multi-institutional database[J]. Am J Obstet Gynecol MFM, 2023, 5:100854. |